Aonong Group(SH:603363) Shang Hai Zheng Quan Bao·2026-01-27 20:10Core Viewpoint - The announcement details a share reduction plan by major shareholders of Aonong Biological Technology Group Co., Ltd., indicating a potential decrease in shareholding and its implications for the company [1][2]. Shareholder Holdings - As of the announcement date, the shareholders include: - China Foreign Economic and Trade Trust Co., Ltd. - Foreign Trade Trust - Xuanwu No. 13 Collective Fund Trust Plan holds 65,000,000 shares, accounting for 2.4972% of the total share capital - Xiamen International Trust Co., Ltd. - Xiamen Trust - Aochuang Zhihe No. 1 Asset Service Trust holds 123,000,000 shares, accounting for 4.7254% - Beijing Yawen Chunya Technology Development Center (Limited Partnership) holds 20,000,000 shares, accounting for 0.7684% [1]. Reduction Plan Details - The reduction plan involves: - Foreign Trade Trust plans to reduce up to 15,665,973 shares - Xiamen Trust plans to reduce up to 5,543,344 shares - Beijing Yawen plans to reduce up to 4,820,299 shares - The total reduction will not exceed 1% of the company's total share capital [2][4]. Shareholder Agreement - The reducing shareholders have no concerted action parties - They signed a "Concerted Action Agreement" on December 25, 2024, to act in unison regarding shareholder rights for a period of 12 months, ending on December 27, 2025 [3]. Compliance with Regulations - The shareholders have committed to not transferring or entrusting their shares for 12 months following the acquisition of restructured investment shares - The planned reduction aligns with previously disclosed commitments [5][6]. Monitoring and Disclosure - The company will continue to monitor the progress of the reduction plan and fulfill its information disclosure obligations as required [7]. Announcement Date - The announcement was made on January 28, 2026 [8].